BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Trade Payables History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Trade Payables | ₹71 Cr | ₹59 Cr | ₹40 Cr | ₹32 Cr | ₹20 Cr |
What is the latest Trade Payables ratio of BETA DRUGS ?
| Year | Trade Payables |
|---|---|
| Mar2025 | ₹71 Cr |
| Mar2024 | ₹59 Cr |
| Mar2023 | ₹40 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹20 Cr |
How is Trade Payables of BETA DRUGS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2025 | ₹71 Cr | 20.20 | |
| Mar2024 | ₹59 Cr | 47.30 | |
| Mar2023 | ₹40 Cr | 25.94 | |
| Mar2022 | ₹32 Cr | 55.91 | |
| Mar2021 | ₹20 Cr | - | |
Compare Trade Payables of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,296.7 Cr | -5.3% | 41.1% | 20.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -5.3% |
41.1% |
20.9% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses